Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group.
about
Topical corticosteroids as adjunctive therapy for bacterial keratitisTopical corticosteroids as adjunctive therapy for bacterial keratitisEffect of topical fluoroquinolones on the expression of matrix metalloproteinases in the corneaVisual outcomes in treated bacterial keratitis: four years of prospective follow-upSimplifying collection of corneal specimens in cases of suspected bacterial keratitis.Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases.Severe infective keratitis leading to hospital admission in New ZealandThe efficacy and safety of topical polymyxin B, neomycin and gramicidin for treatment of presumed bacterial corneal ulcerationInfective keratitis in older patients: a 4 year review, 1998-2002.Initial therapy for suppurative microbial keratitis in Iraq.Predictors of outcome in fungal keratitis.The steroids for corneal ulcers trial: study design and baseline characteristics.Impression membrane for the diagnosis of microbial keratitis.Microbial keratitis: what's the preferred initial therapy? View 2: Empirical fluoroquinolone therapy is sufficient initial treatment.Genetic characterization indicates that a specific subpopulation of Pseudomonas aeruginosa is associated with keratitis infections.Microbiological findings and predisposing risk factors in corneal ulcers.Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study
P2860
Q24193096-C56C6258-D90E-40E7-A324-CF5C42189A8DQ24243055-B67C16D1-C505-4B37-8D11-B67740B60C57Q24805406-136CB5B4-950D-4C02-9287-6A6E971E655EQ33567447-CCD73E17-F487-4DF8-96E9-CF4EACF5A49FQ35156428-10E5990D-676D-431D-8434-8AF14A4318A9Q35156993-C818F66F-2ECB-41AA-ACDB-3F3AED4D26BCQ35591453-1DE58D67-28EC-4711-B5F9-F5EEDCAE7480Q35591605-56721DD7-D61B-40A7-B6C5-7AF70245793CQ35593190-3BB8622F-4025-494A-BA0B-AD4B1EEBA869Q36172333-E487882E-508F-4FE6-971A-12607536DAB2Q36238361-49D79F8B-D4D0-4411-A305-C561B7FF50A6Q37315329-02EE59A1-F0F6-48C4-9F58-850BB0CFA9EDQ40996033-73CC74D1-8DE5-4016-8F42-FDB11B967ACDQ41981832-7CA75176-889A-445D-9AB4-16750B5C9DA7Q42686134-9F0A0A21-DFF1-46C4-9851-C5E92B5F1B8EQ51384054-BEDCCA74-7C43-41B5-BFC0-ED6176F4E6A5Q57210886-EDC2720D-2794-4DAE-9BDA-889305D91DAB
P2860
Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Risk factors for treatment out ...... atitis. Ofloxacin Study Group.
@ast
Risk factors for treatment out ...... atitis. Ofloxacin Study Group.
@en
type
label
Risk factors for treatment out ...... atitis. Ofloxacin Study Group.
@ast
Risk factors for treatment out ...... atitis. Ofloxacin Study Group.
@en
prefLabel
Risk factors for treatment out ...... atitis. Ofloxacin Study Group.
@ast
Risk factors for treatment out ...... atitis. Ofloxacin Study Group.
@en
P2093
P2860
P356
P1476
Risk factors for treatment out ...... atitis. Ofloxacin Study Group.
@en
P2093
P2860
P304
P356
10.1136/BJO.83.9.1027
P407
P577
1999-09-01T00:00:00Z